COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration

COVID-19 Briefings

Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.


Actionable Analysis News and Intelligence From Interviews with Leading Nationwide Experts

Analysis of nationwide clinical laboratory COVID-19 lab test reports

Redfield Defends Bypassing the CDC on Crucial COVID-19 Data

The National Healthcare Safety Network (NHSN) module was one of four pathways to reporting crucial COVID-19 data to HHS. The NHSN module was deactivated with the TeleTracking HHS Protect portal becoming the primary pathway for hospitals, hospital laboratories, and other healthcare facilities. The decision has met criticism.

Read More

Life After COVID: Positioning Your Lab for Success in a Post-Pandemic World

Now available for streaming: How does your lab begin to prepare itself to succeed in a post-pandemic world? Start your plan now to navigate the transition. Attend this complimentary webinar and hear the ways in which your lab’s current testing can create assets for the future, and how you can best position your lab for success in a post-pandemic environment by leveraging your diagnostic data as a strategic asset.

Read More »

Emerging SARS-CoV-2 Mutations: Impact on Thermo Fisher Scientific Assay Performance

Available for free streaming: Learn the important clinical implications (epidemiological, prognostic, and predictive) of new COVID-19 “variants of concern,” the importance of early detection of these variants, and steps your lab can take to confidently detect the COVID-19 virus with a very high degree of specificity and sensitivity, given new variants.

Read More »
COVID checklist

Achieving High Confidence Levels in the Quality and Accuracy of Your Clinical Lab’s Chosen COVID-19 Serology Tests

Now that your clinical laboratory has decided on which COVID-19 serology test it will buy and offer to physicians, patients, and employers with wellness screening programs, your lab team must succeed with the challenging process of validation. This is required—not just for your lab to meet CLIA requirements—but for your lab team to have high confidence that the COVID-19 serology test results are accurate, reproducible, and appropriate for use in patient care. Join us for this program as James O. Westgard and Sten Westgard, lead you through the process. 

Read More »